Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Visit the official website of the International Institute of Anticancer Research

Current Issue

June 2026 (Vol. 46 Issue 6) Table of Contents
Anticancer Research: 46 (6)

Issue highlights

  • A Landscape of Immunogenomics Assessments for Endemic Burkitt Lymphoma: Relevance to Outcomes
  • Beneficial Effects of Combining an Immune Checkpoint Inhibitor With Proton Radiation, OXi4503, or Hyperthermia in a Murine Solid Tumor Model
  • A RANKL-derived Peptide Inhibits RSPO3-LGR4-Wnt Signaling and Lung Adenocarcinoma in Mice
  • Targeting Arginine Metabolism to Reverse Immune Paralysis in Cancer
  • Prior Chlamydia trachomatis Infection and the Risk of Epithelial Ovarian Cancer and Borderline Ovarian Tumors

 


 

The new Special Issue on "​Ovarian Cancer Immunology and Immunotherapy– 2026" is now published and you may find it here.

Featured Articles

  • Patient-derived Orthotopic Xenograft (PDOX) Nude Mouse Model of Soft-tissue Sarcoma More Closely...
    February 09, 2015
  • Long Noncoding RNA ANRIL Regulates Proliferation of Non-small Cell Lung Cancer and...
    September 25, 2015
  • The Effect of Various Doses of Oral Vitamin D3 Supplementation on Gut Microbiota in...
    December 31, 2019
  • Combination Immunotherapy with 4-1BB Activation and PD-1 Blockade Enhances Antitumor Efficacy in a...
    December 30, 2014
  • Curcumin and Epigallocatechin Gallate Inhibit the Cancer Stem Cell Phenotype via Down-...
    December 30, 2014
  • A Long Noncoding RNA, lncRNA-ATB, Is Involved in the Progression and Prognosis of Colorectal Cancer
    March 06, 2015

Latest Articles

  • Open Access
    A Landscape of Immunogenomics Assessments for Endemic Burkitt Lymphoma: Relevance to Outcomes
    TAHA I. HUDA, RAHUL JAIN, TUSHAR SINGH and GEORGE BLANCK
    Anticancer Research June 2026, 46 (6) 3231-3242; DOI: https://doi.org/10.21873/anticanres.18193
  • Open Access
    Prognostic and Neurological Outcomes Following Surgery for Spinal NF2-Associated Ependymomas With Cysts
    FLORIAN GRIMM, TIM M. MÜLHÖFER, ULRIKE ERNEMANN, MARTIN U. SCHUHMANN, JOHANNES A. KOEPPEN, MARCOS TATAGIBA, VICTOR-FELIX MAUTNER and ISABEL GUGEL
    Anticancer Research June 2026, 46 (6) 3317-3332; DOI: https://doi.org/10.21873/anticanres.18200
  • Open Access
    Targeting Arginine Metabolism to Reverse Immune Paralysis in Cancer
    GIULIA ELIZABETH BORSATTI, FRANCESCA CUTRUZZOLÀ, SHARON SPIZZICHINO, SERENA RINALDO and ALESSIO PAONE
    Anticancer Research June 2026, 46 (6) 2977-2984; DOI: https://doi.org/10.21873/anticanres.18174
  • You have access
    MMP-9 Genotypes Serve as Oral Cancer Predictive Marker for Smokers
    LIANG-CHUN SHIH, CHE-LUN HSU, YA-CHEN YANG, JAW-CHYUN CHEN, WEN-SHIN CHANG, DA-TIAN BAU and CHIA-WEN TSAI
    Anticancer Research June 2026, 46 (6) 3205-3217; DOI: https://doi.org/10.21873/anticanres.18191
  • You have access
    Antiemetic Efficacy of Aprepitant in Cisplatin–Gemcitabine Therapy for Biliary Tract Cancer: A Multicenter Study
    KENGO UMEHARA, YOSHITAKA SAITO, DAISUKE HIRATE, AYA KOOKA, RYO FUJIBAYASHI, SHUICHI TAKASAKI, TAKASHI SHIMOGUCHIYA, AYUKO KUSAKABE, TOMOAKI HATAKEYAMA, YUKI HASEGAWA, ATSUYA SHIMIZU, AKIHIDE OTA, KENTA MAEDA, TAIKI WATANABE, SHINYA TAKADA, TAKAKO OBARA, HIROYUKI NAGASHIMA, TAMOTSU SAGAWA, KOSHI FUJIKAWA and HIROYUKI KAWAGUCHI
    Anticancer Research June 2026, 46 (6) 3395-3406; DOI: https://doi.org/10.21873/anticanres.18207
  • Open Access
    3D Cancer Cell Model: A New Tool to More Accurately Evaluate the Biological Effect of Cold Plasma
    ROHAN QUONIOU and SEBASTIEN MENECIER
    Anticancer Research June 2026, 46 (6) 2965-2975; DOI: https://doi.org/10.21873/anticanres.18173
View more latest articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention

Visit the official website of Anticancer Research.
Back to top
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire